Pharma Intelligence Award Japan 2022 Commemorative Webinar “PPI Inhibition by Small Molecules: A New Drug Discovery Paradigm”

PRISM BioLab’s proprietary drug discovery platform, PepMetics®, is a technology that enables the control of protein-protein interactions by small molecules with a unique peptide-mimicking backbone, potentially creating a new drug discovery paradigm.

In this webinar, Dai Takehara, President of PRISM BioLab, will introduce the PepMetics® technology and share his experiences in managing a biotech startup, including the status of collaboration with many global pharmaceutical companies, partnering, fundraising and organizational management to realize a new drug discovery paradigm.

Date & Time： November 9, 2022 (Wed.) 16:00-17:00 JST
Format:  Online (Zoom)
Language:  Japanese
Participation Fee:  Free of charge
Registration:  https://app.intelligence.informa.com/e/es?s=383344069&e=766302&elqTrackId=E321630251B995E24C07B6648F7D568D&elq=564aedcf34e841d7b799306ad03646e3&elqaid=34978&elqat=1